# Sutro Biopharma, Inc.: Form 8-K, filed Dec 4, 2020

- Company: [Sutro Biopharma, Inc.](/companies/stro.md) (CIK 1382101)
- Form: 8-K
- Filed: 2020-12-04
- Accepted by EDGAR: Dec 3, 2020, 19:38 ET
- Period: 2020-12-03
- Accession: 0001564590-20-056109
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1382101/000156459020056109/stro-8k_20201203.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1382101/000156459020056109/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1382101/000156459020056109/stro-8k_20201203.htm

Filed Dec 4, 2020.
Source: SEC EDGAR, the filing index for accession 0001564590-20-056109. Last ingested by Listed: Nov 9, 2026, 23:14 ET. No prices; not investment advice.